Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 26Prostatic Neoplasms 24Brain Neoplasms 21Neoplasms 13Glioma 10Head and Neck Neoplasms 8Pancreatic Neoplasms 7Glioblastoma 6Lung Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 5Astrocytoma 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Lymphoma 4Central Nervous System Neoplasms 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Spinal Cord Neoplasms 3Sarcoma 3Liver Neoplasms 3Disease 3Retinoblastoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Oligodendroglioma 2Neurofibromatosis 1 2Meningioma 2Lymphoma, Non-Hodgkin 2

Interventions

Vincristine 1Vinblastine 1Procarbazine 1Prednisone 1Methotrexate 1Mercaptopurine 1Magnetic Resonance Imaging 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Data Collection 1Cytarabine 1Cyclophosphamide 1Blood Specimen Collection 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Ataxia Telangiectasia × Magnetic Resonance Imaging × Clear all
NCT05252819 2024-02-07

Whole Body MRI for Cancer Surveillance in A-T

University of Nottingham

Completed
32 enrolled

Ataxia Telangiectasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡